Citation Impact
Citing Papers
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR -Mutant Lung Cancers
2013 Standout
Features, Evaluation and Treatment Coronavirus (COVID-19)
2020 Standout
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
Breast cancer
2019 Standout
Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy
2017
Interstitial Lung Disease in Inflammatory Myopathies: Clinical Phenotypes and Prognosis
2013
Rethinking the Optimal Duration of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer Throughout the COVID-19 Pandemic
2020
Efficacy of epidermal growth factor receptor inhibitors versus chemotherapy as second-line treatment in advanced non-small-cell lung cancer with wild-type EGFR: A meta-analysis of randomized controlled clinical trials
2014
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
Global optimal eBURST analysis of multilocus typing data using a graphic matroid approach
2009 Standout
Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: Controversies, insights, and changing horizons
2014
Interstitial Lung Diseases Associated with Collagen Vascular Diseases: Radiologic and Histopathologic Findings
2002
Sjögren's syndrome
2005 Standout
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
ESPEN guideline on clinical nutrition in the intensive care unit
2018 Standout
Pathogenesis and Risk Factors for Nontuberculous Mycobacterial Lung Disease
2014
The biology and management of non-small cell lung cancer
2018 StandoutNature
Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancer
2016
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
2015 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
The effect of high-flow nasal cannula in reducing the mortality and the rate of endotracheal intubation when used before mechanical ventilation compared with conventional oxygen therapy and noninvasive positive pressure ventilation. A systematic review and meta-analysis
2017
Lung Cancer
2008 Standout
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer
2013
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
2016 Standout
Network meta-analysis of survival data with fractional polynomials
2011
Dermatologic Reactions to Immune Checkpoint Inhibitors
2017
Lung cancer: current therapies and new targeted treatments
2016 Standout
Stevens–Johnson syndrome during nivolumab treatment of NSCLC
2017
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Interstitial lung disease guideline
2008
Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?
2018
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Treatment and Prognosis of Isolated Local Relapse after Stereotactic Body Radiotherapy for Clinical Stage I Non-Small-Cell Lung Cancer
2015
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial
2013
Acute respiratory distress syndrome
2019 Standout
Idiopathic pulmonary fibrosis
2017 Standout
Patterns of Disease Recurrence after SABR for Early Stage Non–Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy
2015
Sarcopenia
2019 Standout
Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
2012 Standout
Lung-cancer related chest events detected by periodical follow-up CT after stereotactic body radiotherapy for stage I primary lung cancer: retrospective analysis of incidence of lung-cancer related chest events and outcomes of salvage treatment
2012
EGFR tyrosine kinase inhibitorsversuschemotherapy inEGFRwild-type pre-treated advanced nonsmall cell lung cancer in daily practice
2017
Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer
2016
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation
2019
IgG4-related disease
2014 Standout
Pre-existing pulmonary fibrosis is a risk factor for anti-PD-1-related pneumonitis in patients with non-small cell lung cancer: A retrospective analysis
2018
Pulmonary fibrosis and lung carcinoma: A comparative study of metaplastic epithelia in honeycombed areas of usual interstitial pneumonia with or without lung carcinoma
1999
Early prehospital use of non-invasive ventilation improves acute respiratory failure in acute exacerbation of chronic obstructive pulmonary disease
2010
Idiopathic pulmonary fibrosis
2011 Standout
Which Patients With ARDS Benefit From Lung Biopsy?
2015
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
2008
Polymyositis and dermatomyositis
2003 Standout
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Interstitial Lung Disease Associated with Anti-PM/Scl or Anti-Aminoacyl-tRNA Synthetase Autoantibodies: A Similar Condition?
2010
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
2017 Standout
Gefitinib for non-small-cell lung cancer treatment
2011
Spatiotemporal T790M Heterogeneity in Individual Patients with EGFR-Mutant Non–Small-Cell Lung Cancer after Acquired Resistance to EGFR-TKI
2015
Tumour heterogeneity and resistance to cancer therapies
2017 Standout
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
2020 Standout
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
2015 Standout
Salvage surgery after high-dose radiotherapy
2017
Polymyositis–Dermatomyositis-associated Interstitial Lung Disease
2001
Nonspecific Interstitial Pneumonia
1998
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Inflammatory Muscle Diseases
2015 Standout
Development and Validation of a Prognostic Nomogram Based on Clinical and CT Features for Adverse Outcome Prediction in Patients with COVID-19
2020
Acute and subacute idiopathic interstitial pneumonias
2016
Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA)
2014
Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update
2017 Standout
Pemetrexed versus erlotinib in pretreated patients with advanced non–small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 study
2013
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
2001 Standout
Leptomeningeal disease: current diagnostic and therapeutic strategies
2017
Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature
2013
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Infection Source and Epidemiology of Nontuberculous Mycobacterial Lung Disease
2018 Standout
Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study
2015
Polyclonal Population Structure of Streptococcus pneumoniae Isolates in Spain Carrying mef and mef plus erm (B)
2008
Common pitfalls and recommendations for using machine learning to detect and prognosticate for COVID-19 using chest radiographs and CT scans
2020 Standout
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
2015
Targeted therapy for non-small cell lung cancer: current standards and the promise of the future.
2015
2015
Works of Keisuke Tomii being referenced
Prognostic significance of crazy paving ground grass opacities in non-HIV Pneumocystis jirovecii pneumonia: an observational cohort study
2019
Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients—Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study
2016
High-dose erlotinib for refractory leptomeningeal metastases after failure of standard-dose EGFR-TKIs
2015
Surgical Treatment of Local Recurrence After Stereotactic Body Radiotherapy for Primary and Metastatic Lung Cancers
2010
Impact of noninvasive ventilation (NIV) trial for various types of acute respiratory failure in the emergency department; decreased mortality and use of the ICU
2008
Pulmonary involvement in polymyositis and dermatomyositis: sequential evaluation with CT.
1997
Aprepitant for refractory nivolumab-induced pruritus
2017
Early Immune-Related Adverse Events and Association with Outcome in Advanced Non–Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study
2017
Detection of Herpes Viruses by Multiplex and Real-Time Polymerase Chain Reaction in Bronchoalveolar Lavage Fluid of Patients with Acute Lung Injury or Acute Respiratory Distress Syndrome
2013
Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: Clinical benefit with optimal patient selection
2011
A pilot trial of nivolumab treatment for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia
2017
A Case of Isolated IgG4-Related Interstitial Pneumonia
2012
An Open, Noncomparative Multicenter Study of the Efficacy and Safety of Itraconazole Injections and High Dose Capsules in Chronic Pulmonary Aspergillosis
2011
Enteral Nutrition Is a Risk Factor for Airway Complications in Subjects Undergoing Noninvasive Ventilation for Acute Respiratory Failure
2016
Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor
2013
[A probable case of adult Williams-Campbell syndrome incidentally detected by an episode of atypical mycobacterial infection].
1989
[Etiological examination of idiopathic interstitial pneumonia and lung cancer in autopsy cases].
1991
Genotypes and Related Factors Reflecting Macrolide Resistance in Pneumococcal Pneumonia Infections in Japan
2007
Fatal Community-Acquired Primary <i>Candida</i> Pneumonia in an Alcoholic Patient
2012
Prognostic impact of central nervous system metastases after acquired resistance to EGFR-TKI: poorer prognosis associated with T790M-negative status and leptomeningeal metastases.
2015
Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung Cancer
2008
Rebiopsy of non-small cell lung cancer patients with acquired resistance to EGFR-TKI: Comparison between T790M mutation-positive and -negative populations.
2012
Efficacy of High-Flow Nasal Cannula Therapy in Acute Hypoxemic Respiratory Failure: Decreased Use of Mechanical Ventilation
2015
Role of Non-invasive Ventilation in Managing Life-threatening Acute Exacerbation of Interstitial Pneumonia
2010